Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica
Clinical trial NCT05978063 · TERMINATED
Trial details
- NCT number
- NCT05978063
- Sponsor
- Cara Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-04-22
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.